Elisabeth Singer-Mikosch

4PUBLICATIONS
7CO-AUTHORS
Molecular targetsNeurogeneticsGene and molecular therapyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 27, 2024
AAV-Mediated CAG-Targeting Selectively Reduces Polyglutamine-Expanded Protein and Attenuates Disease Phenotypes in a Spinocerebellar Ataxia Mouse Model.

Anna Niewiadomska-Cimicka, Lorraine Fievet, Magdalena Surdyka

|Dec 11, 2022
Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals.

Libo Yu-Taeger, Arianna Novati, Jonasz Jeremiasz Weber

|Apr 03, 2021
The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington's Disease.

Elisabeth Singer, Lilit Hunanyan, Magda M Melkonyan

|Jun 19, 2019
Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease.

Libo Yu-Taeger, Janice Stricker-Shaver, Katrin Arnold

Pageof 1

Frequent Collaborators

3 joint publications

Huu Phuc Nguyen

2 joint publications

Jonasz Jeremiasz Weber

1 joint publications

Lorraine Fievet

1 joint publications

Céline Keime